Portfolio News
2026/01/12
Argo Biopharma to Present at the 44th Annual J.P. Morgan Healthcare Conference
SHANGHAI, CHINA and BOSTON, USA – JANUARY 12, 2026– Argo Biopharmaceutical Co., Ltd. (Argo Biopharma), a clinical-stage biotechnology company committed to developing next-generation siRNA therapies, today announced that Dr. Dongxu Shu, Co-Founder, Chairman of the Board, and Chief Executive Officer will present at the 44th Annual J.P. Morgan Healthcare Conference on Thursday, January 15th 2026 at 1:15 PM PST / 4:15 PM EST. in San Francisco, CA.
